Pharmamar
Clinical trials sponsored by Pharmamar, explained in plain language.
-
New drug PM54 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called PM54 in about 125 adults with advanced solid tumors that have not responded to standard treatments. The first part finds the safest dose by monitoring side effects; the second part checks how well the drug shrinks tumors. The goal is…
Phase: PHASE1 • Sponsor: PharmaMar • Aim: Disease control
Last updated May 17, 2026 04:17 UTC
-
New drug cocktail aims to stall rare Cancer's spread
Disease control Recruiting nowThis study tests whether adding lurbinectedin to standard chemotherapy (doxorubicin) helps people with metastatic leiomyosarcoma live longer without their cancer growing. About 450 adults who have not had prior treatment for advanced disease will receive either the combination or…
Phase: PHASE3 • Sponsor: PharmaMar • Aim: Disease control
Last updated May 07, 2026 18:42 UTC